Richardpruen (talk | contribs) (Added section for ethics and 1 journal special edition, and a paper on Australia) |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
'''Studies, Surveys, Papers, and Case Studies''' | '''Studies, Surveys, Papers, and Case Studies''' | ||
*Sometimes it's necessary to view the PDF version to access the full study. | *Sometimes it's necessary to view the PDF version to access the full study. | ||
*This page is for referencing the possible benefits of [[Abbreviations|'''ENDS''']] products vs. smoking cigarettes from a Public Health standpoint. (Electronic Nicotine Delivery Systems are also known as vapor technology, | *This page is for referencing the possible benefits of [[Abbreviations|'''ENDS''']] products vs. smoking cigarettes from a Public Health standpoint. (Electronic Nicotine Delivery Systems are also known as vapor technology, e-cigarettes, ecigs, EVP, etc.) | ||
*If you'd prefer someone else to add a study to a topic, there is a subject section called "Suggested studies to add to this page". You may put the link in that section for one of the regular page editors to address. | *If you'd prefer someone else to add a study to a topic, there is a subject section called "Suggested studies to add to this page". You may put the link in that section for one of the regular page editors to address. | ||
*If you'd like to help add content to this page, please see the directions at the bottom of the page. | *If you'd like to help add content to this page, please see the directions at the bottom of the page. | ||
| Line 326: | Line 326: | ||
===2018: [https://pubmed.ncbi.nlm.nih.gov/29570695/ Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users]=== | ===2018: [https://pubmed.ncbi.nlm.nih.gov/29570695/ Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users]=== | ||
“Conclusion: Within the study limitations, EC use may help smokers attenuate cigarette consumption or remain abstinent, as well as reduce their post-cessation weight increase. The potential role of the e-vapour category for harm minimization in relation to tobacco and/or food abuse requires confirmation from larger prospective studies. Moreover, the observed lack of post-cessation weight gain in those who reduced substantially cigarette consumption by switching to ECs (i.e., dual users) is an interesting finding and calls for further research investigating the role of nicotine in weight control. Meanwhile, these preliminary findings should be communicated to smokers and particularly to weight-conscious smokers intending to quit. | *“Conclusion: Within the study limitations, EC use may help smokers attenuate cigarette consumption or remain abstinent, as well as reduce their post-cessation weight increase. The potential role of the e-vapour category for harm minimization in relation to tobacco and/or food abuse requires confirmation from larger prospective studies. Moreover, the observed lack of post-cessation weight gain in those who reduced substantially cigarette consumption by switching to ECs (i.e., dual users) is an interesting finding and calls for further research investigating the role of nicotine in weight control. Meanwhile, these preliminary findings should be communicated to smokers and particularly to weight-conscious smokers intending to quit. | ||
By combining substantial reduction of smoking with prevention of post-cessation weight gain, EC-based interventions may promote an overall improvement in quality of life. Considering that the negative effects of weight increase could overshadow the health benefits of smoking abstinence, it is important to stimulate more research in this area.” | *By combining substantial reduction of smoking with prevention of post-cessation weight gain, EC-based interventions may promote an overall improvement in quality of life. Considering that the negative effects of weight increase could overshadow the health benefits of smoking abstinence, it is important to stimulate more research in this area.” | ||
===2018: [https://pubmed.ncbi.nlm.nih.gov/28525609/ E-cigarettes and Weight Loss—Product Design Innovation Insights From Industry Patents]=== | ===2018: [https://pubmed.ncbi.nlm.nih.gov/28525609/ E-cigarettes and Weight Loss—Product Design Innovation Insights From Industry Patents]=== | ||
| Line 388: | Line 387: | ||
Click on the category link below for more studies by topic on ENDS and Nicotine. | Click on the category link below for more studies by topic on ENDS and Nicotine. | ||
[[ | [[Category:Studies, Surveys, and Papers]] | ||
[[Category:THR Advocacy Group]] | |||
[[Category:Smoking cessation]] | |||
edits